Stoke Therapeutics (STOK)
NASDAQ:STOK
Want to see STOK full AI Analyst Report?
Stoke Therapeutics (STOK) Ownership Overview
7.11% Insiders
18.33% Mutual Funds
53.98% Other Institutional Investors
13.85% ETFs
6.72% Public Companies and
Individual Investors
The ownership structure of Stoke Therapeutics (STOK) stock is a mix of institutional, retail, and individual investors. Approximately 86.17% of the company’s stock is owned by Institutional Investors, 7.11% is owned by Insiders, and 6.72% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Mar 19, 2026 | xxxxxxxxxxxxx | $285849 | |
Mar 19, 2026 | xxxxxxxxxxxxx | $119289 | |
Mar 19, 2026 | xxxxxxxxxxxxx | $147118 | |
Aug 20, 2025 | xxxxxxxxxxxxx | $30681 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $3667135 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $2735040 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $995652 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 17,161,713 | Insider | 27.56% | 532,013,103 | |
| 3,336,697 | Institution | 5.36% | 103,437,607 | |
| 2,805,645 | Institution | 4.50% | 86,974,995 | |
| 2,375,568 | Institution | 3.81% | 73,642,608 | |
| 2,296,851 | Institution | 3.69% | 71,202,381 | |
| 1,823,500 | Institution | 2.93% | 56,528,500 | |
| 1,542,594 | Institution | 2.48% | 47,820,414 | |
| 1,369,389 | Institution | 2.20% | 42,451,059 | |
| 1,198,602 | Institution | 1.92% | 37,156,662 | |
| 702,700 | Institution | 1.13% | 21,783,700 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,296,851 | Institution | 3.69% | 71,202,381 | |
| 1,542,594 | Institution | 2.48% | 47,820,414 | |
| 1,198,602 | Institution | 1.92% | 37,156,662 | |
| 702,700 | Institution | 1.13% | 21,783,700 | |
| 677,952 | Institution | 1.09% | 21,016,512 | |
| 532,900 | Institution | 0.86% | 16,519,900 | |
| 483,244 | Institution | 0.78% | 14,980,564 | |
| 481,682 | Institution | 0.77% | 14,932,142 | |
| 477,875 | Institution | 0.77% | 14,814,125 | |
| 452,134 | Institution | 0.73% | 14,016,154 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,732,568 | Institution | 2.78% | 53,553,677 | |
| 1,262,682 | Institution | 2.03% | 38,208,757 | |
| 1,148,330 | Institution | 1.84% | 35,598,230 | |
| 581,949 | Institution | 0.93% | 17,988,044 | |
| 405,902 | Institution | 0.65% | 12,582,962 | |
| 327,343 | Institution | 0.53% | 10,147,633 | |
| 251,608 | Institution | 0.40% | 7,777,203 | |
| 247,594 | Institution | 0.40% | 7,492,194 | |
| 195,704 | Institution | 0.31% | 6,066,824 | |
| 195,369 | Institution | 0.31% | 5,911,866 |
FAQ
Who Owns Stoke Therapeutics (STOK)?
According to the latest TipRanks data, approximately 53.98% of the company's stock is held by institutional investors, 7.11% is held by insiders, and 6.72% is held by retail investors.
What percentage of Stoke Therapeutics (STOK) stock is held by institutional investors?
According to the latest TipRanks data, approximately 53.98% of Stoke Therapeutics (STOK) stock is held by institutional investors.
What percentage of Stoke Therapeutics (STOK) stock is held by retail investors?
According to the latest TipRanks data, approximately 6.72% of Stoke Therapeutics (STOK) stock is held by retail investors.
Who owns the most shares of Stoke Therapeutics (STOK)?
Seth Loring Harrison owns the most shares of Stoke Therapeutics (STOK).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.